CAMP

MKT CAP:$91M

CAMP4 Therapeutics Corporation

Market Cap

$91M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.44-$1.56 (-26.00%)

Apr 23, 2026

Company Details

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CEO

Joshua Mandel-Brehm

IPO Date

Oct 11, 2024

Website

www.camp4tx.com

Key Metrics TTM

Revenue

$3M

+436.5% YoY

Net Income

-$80M

EPS (Diluted)

-$2.59

Free Cash Flow

-$30M

Revenue / Share

$0.07

Gross Margin

77.5%

Operating Margin

-1488.3%

Net Margin

-2298.5%

FCF Margin

-852.8%

P/S

26.0x

P/E

—

Earnings Reports

Q1 2026

May 12, 2026

PENDING

FY 2025

Mar 5, 2026

$3M+436.5%EPS -$2.65

Q4 2025

Mar 5, 2026

$348.0K-46.6%EPS -$0.78

Q3 2025

Nov 6, 2025

$795.0KEPS -$0.55

Q2 2025

Aug 14, 2025

$1MEPS -$0.62

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$79M	$33M	-$998.0K
Q4 21	$69M	$28M	-$7M
Q1 22	$68M	$28M	-$4M
Q2 22	$65M	$26M	-$9M
Q3 22	$73M	$29M	-$5M
Q4 22	$79M	$27M	-$4M
Q3 23	$350.0K	$350.0K	-$12M
Q4 23	$0	$0	-$13M
Q1 24	$0	$0	-$13M
Q2 24	$0	$0	-$13M
Q3 24	$0	$0	-$14M
Q4 24	$652.0K	$652.0K	-$14M
Q1 25	$858.0K	$858.0K	-$13M
Q2 25	$1M	$1M	-$13M
Q3 25	$795.0K	$379.0K	-$13M
Q4 25	$348.0K	-$24.0K	-$13M

Valuation

Quarter	P/S	P/E
Q3 21	0.3x	—
Q4 21	0.3x	—
Q1 22	0.3x	—
Q2 22	0.3x	—
Q3 22	0.3x	—
Q4 22	0.3x	—
Q3 23	0.4x	—
Q4 23	0.6x	—
Q1 24	1.1x	—
Q2 24	259.7x	—
Q3 24	—	—
Q4 24	139.4x	—
Q1 25	60.2x	—
Q2 25	30.2x	—
Q3 25	23.9x	—
Q4 25	26.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$10M	$7M
Q4 21	-$7M	-$11M
Q1 22	-$8M	-$10M
Q2 22	-$16M	-$19M
Q3 22	-$10M	-$11M
Q4 22	$4M	-$569.0K
Q3 23	-$7M	-$7M
Q4 23	-$12M	-$12M
Q1 24	-$11M	-$11M
Q2 24	-$13M	-$14M
Q3 24	-$10M	-$10M
Q4 24	-$11M	-$12M
Q1 25	-$14M	-$15M
Q2 25	-$10M	-$10M
Q3 25	-$11M	-$11M
Q4 25	$6M	$6M

Capital Expenditures

Quarter	CapEx
Q3 21	$3M
Q4 21	$4M
Q1 22	$3M
Q2 22	$4M
Q3 22	$1M
Q4 22	$4M
Q3 23	$207.0K
Q4 23	$243.0K
Q1 24	$15.0K
Q2 24	$163.0K
Q3 24	$0
Q4 24	$263.0K
Q1 25	$279.0K
Q2 25	$0
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	-5.4%	-10.9%
Q4 21	-21.9%	-30.3%
Q1 22	-16.6%	-11.5%
Q2 22	-18.8%	-8.5%
Q3 22	-7.8%	-2.3%
Q4 22	+14.7%	+9.5%
Q3 23	-99.5%	-82.6%
Q4 23	-100.0%	-81.8%
Q1 24	-100.0%	-83.5%
Q2 24	-100.0%	-84.7%
Q3 24	-100.0%	+6.5%
Q4 24	—	+9.0%
Q1 25	—	+8.4%
Q2 25	—	+14.7%
Q3 25	—	+3.2%
Q4 25	-46.6%	-10.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$3M	3.7%
Q4 21	$3M	4.6%
Q1 22	$3M	4.0%
Q2 22	$3M	4.6%
Q3 22	$3M	4.4%
Q4 22	$2M	2.6%
Q3 23	$722.0K	206.3%
Q4 23	$636.0K	—
Q1 24	$856.0K	—
Q2 24	$786.0K	—
Q3 24	$2M	—
Q4 24	$797.0K	122.2%
Q1 25	$861.0K	100.3%
Q2 25	$1M	66.9%
Q3 25	$984.0K	123.8%
Q4 25	$1M	330.7%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 21	$8M	$13M	$12M	—
Q4 21	$7M	$13M	$13M	—
Q1 22	$7M	$14M	$11M	—
Q2 22	$7M	$15M	$11M	—
Q3 22	$7M	$14M	$13M	—
Q4 22	$5M	$11M	$12M	—
Q3 23	$10M	$3M	—	—
Q4 23	$11M	$3M	—	—
Q1 24	$10M	$3M	—	—
Q2 24	$9M	$3M	—	—
Q3 24	$10M	$4M	—	—
Q4 24	$10M	$5M	—	—
Q1 25	$10M	$4M	—	—
Q2 25	$10M	$4M	—	—
Q3 25	$9M	$5M	—	—
Q4 25	$8M	—	—	$5M

Revenue Segments

Quarter	Application Subscriptions And Other Services	Product
Q3 21	$27M	$52M
Q4 21	$28M	$40M
Q1 22	$29M	$39M
Q2 22	$25M	$39M
Q3 22	$27M	$46M
Q4 22	$26M	$53M
Q4 23	$22M	$31M

Revenue by Geography

Quarter	All Other	Asia Pacific	E M E A	South America	U S	L A S F	United States	Latin America	Emea
Q3 21	$1M	$3M	$13M	$8M	$54M	—	—	—	—
Q4 21	$770.0K	$6M	$12M	—	$45M	$6M	—	—	—
Q1 22	$444.0K	$3M	$12M	—	—	$5M	$47M	—	—
Q2 22	$589.0K	$5M	$13M	—	—	—	$40M	$6M	—
Q3 22	$534.0K	$6M	$12M	—	—	—	$46M	$8M	—
Q4 22	$2M	$3M	$15M	—	—	—	$50M	$9M	—
Q4 23	$2M	$5M	—	—	—	—	$29M	$4M	$14M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$79M	$0	$79M
Q2 22	$59M	$0	$59M
Q3 22	$48M	$0	$48M
Q4 22	$45M	$0	$45M
Q1 23	$42M	$0	$42M
Q2 23	$35M	$0	$35M
Q3 23	$39M	$0	$39M
Q4 23	$38M	$0	$38M
Q1 24	$13M	$0	$13M
Q2 24	$13M	$0	$13M
Q3 24	$3M	$0	$3M
Q4 24	$64M	$0	$64M
Q1 25	$49M	$0	$49M
Q2 25	$39M	$0	$39M
Q3 25	$75M	$0	$75M
Q4 25	$110M	$0	$110M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	35M	+0.9%	+2.6%
Q4 21	35M	+0.9%	+2.5%
Q1 22	36M	+0.2%	+2.5%
Q2 22	36M	+0.5%	+2.5%
Q3 22	36M	+0.8%	+2.4%
Q4 22	36M	+1.0%	+2.5%
Q3 23	37M	+1.7%	+4.0%
Q4 23	37M	+1.2%	+4.8%
Q1 24	12M	-67.6%	-66.3%
Q2 24	16M	+30.4%	-56.5%
Q3 24	20M	+23.3%	-47.3%
Q4 24	20M	0.0%	-47.9%
Q1 25	20M	0.0%	+60.9%
Q2 25	20M	+3.4%	+27.5%
Q3 25	20M	0.0%	+3.4%
Q4 25	52M	+157.5%	+166.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	$65	10K
Q1 25	$86	10K
Q2 25	$150	10K
Q3 25	$80	10K
Q4 25	$17	21K

Revenue / Employee